Kronos Bio Aktie

Watchlist KRON WKN A2QD64 ISIN US50107A1043

Was macht Kronos Bio?

Unternehmensprofil
Unternehmensprofil

Kronos Bio, Inc. is a clinical development biopharmaceutical company. It engages in the business of developing therapeutics that target dysregulated transcription that causes cancer and other serious diseases. The company was founded by Arie S. Belldegrun, Joshua A. Kazam, David M. Tanen, and Christopher Wilfong on June 2, 2017 and is headquartered in San Mateo, CA.

Chart der Kronos Bio Aktie

Charttool öffnen

Aktuelle Nachrichten zu Kronos Bio

Unsere neuesten Artikel zu Kronos Bio